scispace - formally typeset
C

Candido Gude

Researcher at Merck & Co.

Publications -  40
Citations -  920

Candido Gude is an academic researcher from Merck & Co.. The author has contributed to research in topics: Thromboxane-A synthase & Thromboxane receptor. The author has an hindex of 16, co-authored 40 publications receiving 858 citations. Previous affiliations of Candido Gude include Novartis & Ciba Specialty Chemicals.

Papers
More filters
Journal ArticleDOI

Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease.

TL;DR: CGS 16949 A's ability to selectively inhibit aromatase (IC50 = 4.5 nM) over other cytochrome P-450 enzymes and suppress estrogen production when administered orally make it a suitable candidate to test the potential of an aromat enzyme inhibitor in estrogen-dependent diseases including breast cancer.
Journal ArticleDOI

Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.

TL;DR: The synthesis and structure-activity profile of a new class of potent and highly specific thromboxane A2 synthetase inhibitors is described and the most potent member of this series in vitro is determined to be imidazo[1,5-a]-pyridine-5-hexanoic acid.
Journal ArticleDOI

Angiotensin converting enzyme inhibitors: 1-glutarylindoline-2-carboxylic acids derivatives.

TL;DR: The preparation of a series of 1-glutarylindoline-2(S)-carboxylic acid derivatives, 6a-v and 21a-c, is described and the structure-activity relationship of the series is discussed.
Journal ArticleDOI

Synthesis of 4-substituted phenylalanines by cross-coupling reactions : extension of the methodology to aryl chlorides

TL;DR: The Suzuki-Miyaura coupling reactions with aromatic chlorides in the presence of catalytic amounts of PdCl2 (PCy3)2 or NiCl2(dppf) were used to produce 4-substituted phenylalanine derivatives as discussed by the authors.